When the MIT Enterprise Forum of Cambridge presents its upcoming event focused on CRISPR technology, this controversial genetic research will be discussed from all sides — as a huge technology breakthrough, as a complex ethical and regulatory issue, and in terms of what this research means to ordinary human beings facing the unimaginable crisis of hearing that their son has a fatal and incurable genetic disease.

That’s the story Andrés Treviño will be sharing as a member of this event’s distinguished panel. Listen to a preview now in this MIT Enterprise Forum of Cambridge Thought Leadership Podcast.